Article

The New York TimesThe New York Times on 2017-07-25 16:37

The Tasmanian Hep C Buyers’ Club

An innovative Australian takes a cue from early AIDS fighters to distribute generic new drugs that treat another potential killer, hepatitis C.

Related news